NCT00744445View on ClinicalTrials.gov

Erythropoietin Therapy in Patients With Chronic Renal Failure: A Study of Time Dependent Activity

PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

October 31, 1993

Primary Completion Date

August 31, 1998

Study Completion Date

August 31, 1998

Conditions
HemodialysisChronic Renal FailureAnemia
Interventions
DRUG

r-HuEPO

r-HuEPO 50 U/kg s.c. three times per week. The dose is rounded to the nearest 2000 unites.

All Listed Sponsors
lead

Sunnybrook Health Sciences Centre

OTHER